Organigram Global (OGI) Income from Continuing Operations (2018 - 2026)
Organigram Global (OGI) posted quarterly Income from Continuing Operations of 13889910.02 for Q1 2026, down 53.06% year-over-year from 29588285.91 in Q1 2025, and up 3973.99% quarter-over-quarter from 358543.14 in Q4 2025.
Organigram Global (OGI) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Income from Continuing Operations for 7 consecutive years, with 13889910.02 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 53.06% year-over-year to 13889910.02; the TTM figure through Mar 2026 stood at 38251162.78 (up 84.68% YoY), while the FY2025 annual figure was 13050970.35, changed N/A from the prior year.
- Income from Continuing Operations rose to 13889910.02 in Q1 2026 per OGI's latest filing, from 358543.14 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 29588285.91 in Q1 2025 and bottomed at 4868490.0 in Q4 2024.
- Historically, Income from Continuing Operations has averaged 9562790.7 across 3 years, with a median of 6765683.44 in 2025.
- Annual changes were most pronounced in 2025 — Income from Continuing Operations surged 92.64% — and 2026, when it sank 53.06%.
- Organigram Global's Income from Continuing Operations stood at 4868490.0 in 2024, then soared by 92.64% to 358543.14 in 2025, then soared by 3973.99% to 13889910.02 in 2026.
- Business Quant data shows OGI's Income from Continuing Operations at 13889910.02 in Q1 2026, 358543.14 in Q4 2025, and 29588285.91 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Organigram Global | 152.57 Mn | 152.45 Mn | 28.97 Mn | 13.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.89 Mn |
| Dec 31, 2025 | -358,543.14 |
| Mar 31, 2025 | 29.59 Mn |
| Dec 31, 2024 | -4.87 Mn |
| May 31, 2021 | -104.73 Mn |
| Feb 28, 2021 | 100.73 Mn |
| Nov 30, 2020 | -34.34 Mn |
| Aug 31, 2020 | -166.07 Mn |
| May 31, 2020 | -64.27 Mn |
| Feb 29, 2020 | -6.83 Mn |
| Nov 25, 2019 | 15.25 Mn |
| Aug 31, 2019 | -19.79 Mn |
| May 31, 2019 | -7.60 Mn |
| Feb 28, 2019 | -6.39 Mn |
| Nov 30, 2018 | 29.52 Mn |
| May 31, 2018 | 4.09 Mn |